Publication | Open Access
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study
40
Citations
18
References
2022
Year
Secukinumab appears to be effective for the treatment of palmoplantar psoriasis also in the real-life setting.
| Year | Citations | |
|---|---|---|
Page 1
Page 1